trending Market Intelligence /marketintelligence/en/news-insights/trending/vEczJjaWSWD5NGoJr01qMw2 content esgSubNav
In This List

Recro Pharma plans to sell $40M of common stock

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global M&A By the Numbers: Q2 2021

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times


Recro Pharma plans to sell $40M of common stock

Recro Pharma, Inc. plans to sell up to $40 million of its common shares from time to time.

Cowen and Co. LLC will act as the placement agent for the offering.